Dr. Earl A. Zimmerman, MD

Expert Publications

• High-field magnetic resonance imaging of brain iron: birth of a biomarker?
• 1H MR spectroscopy using TE averaged PRESS: a more sensitive technique to detect neurodegeneration associated with Alzheimer's disease.
• Magnetic field correlation as a measure of iron-generated magnetic field inhomogeneities in the brain.
• Iron accumulation in the substantia nigra of patients with Alzheimer disease and parkinsonism.
• Ideal management of diabetes mellitus and dementia: walking a tightrope between hyperglycemia and hypoglycemia.
• Improved myo-inositol detection through Carr-Purcell PRESS: a tool for more sensitive mild cognitive impairment diagnosis.
• Polybrominated diphenyl ethers (PBDEs), polychlorinated biphenyls (PCBs) and neuropsychological status among older adults in New York.
• Exergaming and older adult cognition: a cluster randomized clinical trial.
• Raman spectroscopy of blood serum for Alzheimer's disease diagnostics: specificity relative to other types of dementia.
• Anti-Ri-associated paraneoplastic brainstem cerebellar syndrome with coexisting limbic encephalitis in a patient with mixed large cell neuroendocrine lung carcinoma.

Clinical Trials

• 221AD301 Phase 3 Study of Aducanumab (BIIB037) in Early Alzheimer's Disease

Media Releases

Get to know Neurologist Dr. Earl A. Zimmerman, who serves patients in Albany, New York.

A New York-based neurologist, Dr. Zimmerman is the Founder and Director of the Alzheimer’s Center at Albany Medical Center, and serves as a Professor of Neurology at Albany Medical College. He specializes in behavioral neurology and the diagnosis and treatment of dementia.

As the Director of an Alzheimer’s Disease Center of Excellence for the Capital Region of New York, his major focus is the education of physicians in the diagnosis and care of patients with Alzheimer’s disease and dementia. His current research is focused on new diagnostic methods for early detection and measures for effectiveness of new treatments for Alzheimer’s disease and other neurological disorders of aging.

In regards to his educational background, Dr. Zimmerman received his undergraduate degree from Franklin and Marshall College, and his medical degree from the University of Pennsylvania. He received his clinical and research training at Columbia Presbyterian Medical Center, where he became professor of neurology and well known for his research in neuroendocrinology.

As a testament to his success, the doctor is board-certified in neurology by the American Board of Psychiatry and Neurology (ABPN). The ABPN is a not-for-profit corporation dedicated to serving the professions of psychiatry and neurology.

Moreover, he is board-certified in internal medicine by the American Board of Internal Medicine (ABIM). The ABIM is a physician-led, non-profit, independent evaluation organization driven by doctors who want to achieve higher standards for better care in a rapidly changing world.

In 1985, Dr. Zimmerman became Professor and Chairman of Neurology at Oregon Health and Sciences University in Portland and founded the federally funded Oregon Alzheimer’s Disease Research Center.

Neurology is a branch of medicine dealing with disorders of the nervous system. Neurologists are licensed medical specialists who diagnose and treat disorders that affect the brain, spinal cord, nerves, and muscles of patients. They examine a patient’s mental and physical status, conduct medical tests and scans, and evaluate the results to diagnose and treat the patient.

Recommended Articles

• Vitamin D May Help Improve Balance in Younger Parkinson's Patients

  Can vitamin D help your Parkinson’s balance symptoms subside? It is highly possible. Vitamin D is a natural, anti-inflammatory that is consumable. You can lower the amount of C-reactive protein or the protein that is responsible for most types of inflammation by supplementing your diet with...

• Gabapentin: Abuse, Withdrawal, and Overdose

  Most holistic addiction centers use gabapentin in one form or another to help their patients deal with addiction. However, many patients have started to abuse this drug after prolonged exposure during the course of their rehab process.Gabapentin is usually available in the form of tablets and has...

• Second Opinions for Multiple Sclerosis: When Are They Advisable?

  The decision of whether or not to seek out a second opinion during medical procedures or diagnoses is often uncertain, and many struggle to understand when or how to get one. It is important to follow these guidelines for attaining expertise from an multiple sclerosis specialist, while still...

• What Is a Transient Ischemic Attack (TIA)?

  OverviewA transient ischemic attack (TIA) is a mini-stroke, which only lasts for a few minutes. It occurs when blood stops flowing to a part of the brain for a short time. The symptoms of TIA are similar to other symptoms of stroke, but they do not last long, so TIA does not lead to permanent...

• Parkinson's Disease Can Appear Up to 10 Years Before Diagnosis

  Parkinson’s disease is a long-term neurological disorder that mainly affects the body’s movements. This disorder attacks the muscle control; therefore, involuntary movements of a Parkinson’s disease patient are very evident. Most patients have a hard time controlling their balance and movement...

• Widow Creates Fashion Line to Help Parkinson's Disease Patients

  Maura Horton’s husband, Don, was diagnosed with Parkinson’s Disease when he was just 48 years old. Don was part of the about 1.5 million people who had Parkinson’s disease just in the United States. This progressive disease disrupts the neural circuits that are in the basal ganglia, which is...